|
Bob Finder |
|
Experience Bob has more than 30 years experience in the international pharmaceutical and chemical industries, and has retired as Chief Executive Officer of Novozymes GroPep Limited, the Australian subsidiary of Novozymes, a global biotechnology company. Bob was Managing Director and Chief Executive Officer of GroPep before the Novozymes acquisition from 2002-6. Prior to joining GroPep in 2002, Mr Finder was President and Chief Operating Officer of Mayne Pharma – Americas and Asia Pacific. In this role, Mr Finder was responsible for the commercial activities for the Americas and Asia Pacific region as well as for global research and development for Mayne Pharma. Mayne Pharma evolved from Mayne’s acquisition of F H Faulding, where Bob was President and Chief Operating Officer of Faulding Pharmaceuticals – Asia Pacific. Prior to Faulding, Bob’s roles included Vice President Manufacturing for Ecogen Inc, in Pennsylvania, Director Manufacturing for Rhone-Poulenc (USA) and Managing Director of Monsanto Chemicals in Thailand. He is a Member of the Australian Institute of Company Directors and the American Institute of Chemical Engineers. | |
|
||||||||||||||||||||
|
|
|
|||||||||||||||||||
| © 2008 LBT Innovations Pty Ltd. All rights reserved. | ||||||||||||||||||||
